...
News

nOink offers help to the Big Apple and Garden state

nOink are stepping up in the fight against Coronavirus by offering their healthcare platform to residents of New York and New Jersey. nOink, a UK based software company who’s platform allows users to track any condition are now offering their software platform to the people of New York and New Jersey for free.

"Having lived, worked and met my wife in New York, nOink as a company cannot just sit by when we have technology available right now to help" says nOink Co-founder Dr Liam Holohan.

MORE INFO >

OTHER NEWS

nOink release COVID-19 condition pack

13-MARCH-2020

nOink are happy to announce the release of their Coronavirus (COVID-19) condition pack for their healthcare platform. The COVID-19 condition pack allows users to record all potential COVID-19 symptoms and share this information remotely with their doctors in real time. The condition pack also provides the latest health information on the Coronavirus pandemic from trusted sources such as the WHO, CDC, ECDC, NHS, HSE and others

MORE INFO >

nOink helps PKU

03-JANUARY-2020

nOink have created a PKU (Phenylketonuria) condition pack for their healthcare platform. This condition pack was a departure from previous conditions that the nOink platform cater for in that the current treatment options consist of extreme dietary control rather than medication.

MORE INFO >

nOink extends condition offering

10-SEPTEMBER-2019

nOink have extended its offering to 13 seperate medical conditions on their healthcare platform.

MORE INFO >

nOink works on Cystic Fibrosis

15-JULY-2019

nOink have released a Cystic Fibrosis condition pack for their healthcare platform.

MORE INFO >

nOink helps Brain Tumour patients

04-APRIL-2019

nOink have completed a Brain Tumour condition pack for their healthcare platform.

MORE INFO >

nOink manages Epilepsy

25-MARCH-2019

nOink have finished an Epilepsy condition pack for their healthcare platform.

MORE INFO >

nOink and MKD

18-JANUARY-2019

nOink have just created the world’s first management platform for MKD (Mevalonate Kinase Deficiency), a rare genetic auto-inflammatory disorder and hold out the promise to help many more rare conditions.

MORE INFO >

 
 
© NOINK LIMITED 2020